from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2293c/-

LFCtreatmentdescriptionclass of inhibitor

1.139

Amikacinug/mL Amikacintranslation

0.763

Cap5-10ug/mL Capreomycintranslation

0.605

Rox10-50 ug/mL Roxithromycintranslation

-0.144

SM2-5 ug/mL Streptomycintranslation

1.014

Tet5-10 ug/mL Tetracyclinetranslation

0.584

Rif0.2-5ug/mL Rifampicintranscription

0.513

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.504

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.798

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.673

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.227

Clofazimine10-13 ug/mL Clofaziminerespiration

0.814

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.550

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.330

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.033

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.609

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.087

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.001

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.160

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.329

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.562

KCN5-20 ug/mL Potassium cyaniderespiration

0.501

NaN30.2-2 mM Sodium aziderespiration

-0.090

Nigericin50 uM Nigericinrespiration

0.002

TRC10-150 ug/mL Triclosanrespiration

-1.011

TRZ10-25 ug/mL Thioridazinerespiration

-0.125

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.357

menadione6-10 ug/mL Menadionerespiration

-0.576

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.577

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.475

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.252

NRP_1Non-replicating persistence stage 1dosRassociated

0.432

Amp0.2mg/mL AmpicillincellWall

0.333

Cephalexin20-100 ug/mL CephalexincellWall

0.323

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.334

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.090

EMB10-20 ug/mL EthambutolcellWall

2.146

Eta12-40 ug/mL EthionamidecellWall

0.354

INH0.2-0.4 ug/mL IsoniazidcellWall

0.483

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.875

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.845

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.172

BZA0.12 mg/mL BenzamidearomaticAmides

-0.422

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.592

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.665

H2O24 mM hydrogen peroxideDNAdamaging

0.077

Levo10 ug/mL LevofloxacinDNAdamaging

-0.636

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.309

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.157

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.209

UVUV-irradiationDNAdamaging

-1.216

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.157

Antimycin12.5-50 ug/mL Antimycin A?

0.710

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.045

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.573

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.320

PA8240.2-2 ug/mL PA-824?

0.821

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.099

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.083

mercaptoethanol2 mM 2-Mercaptoethanol?

0.584

methoxatin10-20 ug/mL Methoxatin?